A new study published in the Journal of the American Society of Nephrology (JASN) suggests that taking a single dose of immune system targeting antibody rituximab could lead to a five-fold decrease in relapses of a form of kidney disease for at least one year. For most children and young adults with a kidney disorder called idiopathic nephrotic syndrome (INS), the disease is thought to arise from an abnormal immune response. Researchers have shown that the drug ...
Read MoreYou have just read an article categorized health
titled Rituximab can Lead Five-Fold Reduction in Relapses of Frequently Relapsing Kidney Disease.
Written by:
editor - Friday, January 31, 2014
There are currently no comments for "Rituximab can Lead Five-Fold Reduction in Relapses of Frequently Relapsing Kidney Disease"
Post a Comment